Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy

Victoria S Benson1 GSK, Research and Development Uxbridge, Uxbridge, UKCorrespondence[email protected]

https://orcid.org/0000-0002-3775-1401

Katie C Pascoe1 GSK, Research and Development Uxbridge, Uxbridge, UK

https://orcid.org/0000-0001-5742-4654

James Siddall2 Adelphi Real World, Adelphi Mill, Bollington, UK

Mark Small2 Adelphi Real World, Adelphi Mill, Bollington, UK

Hana Müllerová1 GSK, Research and Development Uxbridge, Uxbridge, UK

https://orcid.org/0000-0002-0949-0101

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bernardino Alcázar-Navarrete, Francisco García-Rio, Guadalupe Sánchez, Esther Mariscal, Andrea García, Maribel Cuesta, Estefany Uría & Marc Miravitlles. (2021) Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2149-2161.
Read now

Articles from other publishers (2)

Alessandro Venosa. (2020) Senescence in Pulmonary Fibrosis: Between Aging and Exposure. Frontiers in Medicine 7.
Crossref

Christian Mang. (2020) Herz und Lunge in der Pneumologie: Pharmakologisch steckt das Organduo in einem Dilemma. Deutsches Ärzteblatt Online.
Crossref

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy

Citations (3)

Read on this site (1)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date